Compare AVAH & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAH | NEOG |
|---|---|---|
| Founded | 1984 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2021 | 1995 |
| Metric | AVAH | NEOG |
|---|---|---|
| Price | $13.37 | $12.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $14.85 | $14.00 |
| AVG Volume (30 Days) | 2.3M | ★ 4.2M |
| Earning Date | 11-12-2026 | 10-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1850.00 | 99.20 |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $2,433,199,000.00 | $870,400,000.00 |
| Revenue This Year | $10.70 | $1.73 |
| Revenue Next Year | $7.63 | N/A |
| P/E Ratio | $35.99 | ★ N/A |
| Revenue Growth | ★ 20.19 | N/A |
| 52 Week Low | $5.93 | $5.37 |
| 52 Week High | $14.71 | $14.26 |
| Indicator | AVAH | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 63.61 | 51.66 |
| Support Level | $12.97 | $11.25 |
| Resistance Level | $14.00 | $12.52 |
| Average True Range (ATR) | 0.36 | 0.64 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 98.24 | 53.51 |
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.